Spine Pain Industry Analysis in United States Revenue to Total US$ 10,962.7 Million by 2033 amid Rising Prevalence of Back Pain: Future Market Insights, Inc.

The increasing incidence of back pain in the United States is a key driver fueling demand for various treatment options. With a growing number of individuals seeking relief, the market is poised for expansion as patients explore diverse interventions to address back pain concerns. This surge in demand is expected to influence the market dynamics significantly during the forecast period.

NEWARK, Del, Dec. 06, 2023 (GLOBE NEWSWIRE) — It is anticipated that the overall revenue generated by spine pain industry analysis in United States will rise from US$ 3,962.7 million in 2023 to US$ 10,962.7 million in 2033. The demand in the nation is expected to increase at a 10.6% CAGR over the projection period.

Spine non-fusion is expected to remain the top product segment in the United States through 2033. This is due to the rising usage of non-fusion products, such as annulus repair devices and artificial disc replacement systems, in spine pain management.

Several factors are anticipated to drive sales growth in the United States during the forecast period. These include the rising incidence of spine pain, surging cases of chronic diseases, increasing preference for minimally invasive procedures, and high demand for different spine pain treatments.

The development of innovative medical technologies and treatment modalities, such as minimally invasive spine surgeries, robotic-assisted procedures, and advanced imaging techniques, can drive sales growth in the United States. These advancements can lead to improved patient outcomes, reduced recovery times, and enhanced precision in diagnosis and treatment.

Get a Sample Copy of the Report:

Spinal cord stimulation (SCS) is one of the most effective technologies that achieve long-term results in patients suffering from chronic neuropathic pain. Hence, novel modalities (high-frequency and burst), techniques, and technical developments of SCS are becoming more popular.

Autoimmune disorders, including ankylosing spondylitis, can trigger inflammation of the spine and sacroiliac joints, causing severe discomfort. As the incidence of these chronic conditions rises due to factors such as an aging population and lifestyle changes, the demand for effective spine pain management will escalate.

This increasing demand for effective spine pain management is expected to drive the healthcare sector to develop targeted treatments that not only alleviate spine pain but also address the root causes. This will bode well for the target business in the United States.

Key Takeaways :

  • Revenue in the United States is expected to reach US$ 10,962.7 million by 2033
  • The total demand in the United States is set to rise at 10.6% CAGR through 2033.
  • By product type, the spinal non-fusion segment is forecast to reach a value of US$ 4,033.3 million by 2033.
  • Based on pain type, the thoracolumbar pain segment is projected to thrive at 8.9% CAGR from 2023 to 2033.
  • By end user, the hospital segment will likely attain a valuation of US$ 1,925.2 million by 2023.

“Rising incidence of back pain and growing popularity of patient-centered care are expected to elevate the demand for spine pain treatment solutions in the United States through 2033,” opines Sabyasachi Ghosh, Associate Vice President at Future Market Insights (FMI).

Competitive Landscape

The landscape in the United States is highly competitive. Key players are constantly innovating and developing novel treatment options in emerging areas. They are also focusing on partnerships to expand in all states.

For instance,

  • In May 2022, the United States Food and Drug Administration (FDA) granted 510(k) clearance to Stryker’s Q Guidance System for enhanced surgical planning.
  • In July 2022, a 3-year agreement to establish the HSS/ZB Innovation Center for AI in Robotic Joint Replacement was announced by the Hospital for Special Surgery (HSS) and Zimmer Biomet Holdings, Inc. It is a leader in medical technology.

Spinal Pain Industry Analysis in United States Report Coverage:

Estimated Size (2023)US$ 3,962.7 million
Projected Value (2033)US$ 10,962.7 million
Anticipated Growth Rate (2023 to 2033)10.6%
Forecast Period2023 to 2033
Historical Data Available for2018 to 2022
Industry AnalysisValue (US$ million)
Key Regions CoveredNortheast, Midwest, Southeast, Southwest, West
Key States CoveredNew York, New Jersey, Massachusetts, Rest of North East, Minnesota, Wisconsin, Rest of Midwest, North Carolina, South Carolina, Florida, Virginia, Rest of Southeast, Louisiana, Oklahoma, Texas, Rest of Southeast, Washington, California, New Mexico, Rest of West
Key Segments CoveredProduct Type, Pain Type, End User, and Region
Key Companies ProfiledZimmer, Inc. (ZimVie Inc.)
Johnson & Johnson
Stryker Corporation
Abbott Laboratories
Boston Scientific Corporation
B Braun (Aesculap, Inc.)
Becton, Dickinson and Company
Globus Medical
Alphatec Spine, Inc.
Nevro Corp
NuVasive, Inc.
Orthofix US LLC.
Surgalign Spine Technologies, Inc.
Precision Spine, Inc.
Report CoverageSales Forecast, Competition Intelligence, Key Dynamics and Challenges, Strategic Growth Initiatives

Unlock Insights & Discounts Now! Click to Gain Your Edge:

Spine Pain Industry Analysis in United States by Category:

By Product Type:

  • Spinal Fusion
    • Interbody Devices
    • Pedicle Screw System
    • Spinal Plating System
  • Spinal Non-Fusion
    • Annulus Repair Devices
    • Artificial Disc Replacement Systems
    • Interspinous Process Decompression (IPD) Devices
    • Pedicle Screw-based Dynamic Stabilization Systems
  • Vertebral Body Replacement Systems
  • Spinal Cord Stimulation
  • Transcutaneous Electrical Neuromuscular Stimulation (TENS)
  • Spinal Epidural Injection

By Pain Type:

  • Cervical Pain
    • Arm Pain
  • Thoracolumbar Pain
    • Arm Pain
    • Leg Pain
  • Lumbar Pain
    • Leg Pain
  • Sciatic Pain
    • Leg Pain

By End User:

  • Hospitals
  • Specialty Clinic
  • Ambulatory Surgical Centers

By Region:

  • Northeast
  • Midwest
  • Southeast
  • Southwest
  • West

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

Explore Future Market Insights, Inc. Extensive Coverage in Healthcare Domain:

Spinal Cord Stimulators Market Outlook: The market size is estimated to register a revenue of US$ 5,441.4 million by 2033.

Joint Replacement Market Trends: A newly released Market analysis report by Future Market Insights shows that global sales of the Joint Replacement Market in 2021 were held at US$ 17.1 Billion.

Spine Pain Market Growth: The global market is expected to reach a valuation of US$ 7.65 Billion in 2023 and is projected to exhibit a compound annual growth rate (CAGR) of 5% from 2023 to 2033.

Back Therapy Kits Market Outlook: The market was valued at US$ 3,700 Million in 2022, and is projected to reach US$ 5,800 Million by 2032 with a CAGR of 4.6%.

Chronic Pain Market Forecast: The market is expected predicted to develop from US$ 73.14 billion in 2023 to US$ 142.53 billion by 2033, mounting at a CAGR of 6.9% over the forecast period.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:       

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries:
LinkedInTwitterBlogs | YouTube

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button